Learning objectives
- Diagnose and treat MDMA toxicity
Definitions and mechanisms
- MDMA (3,4-methylenedioxymethamphetamine) ecstasy is a synthetic compound with structural and pharmacologic similarities to both amphetamines and mescaline
- Typical effects include feelings of euphoria, wakefulness, intimacy, excitement, and a loss of inhibitions
- It is mistakenly believed that it is a safe drug with little toxicity and a long duration of action
- The effects of MDMA typically last anywhere from 3 to 6 hours
- Effects are thought to result from alterations in serotonin, dopamine, and norepinephrine
- The drug is commonly ingested orally in tablet form, however, the powder itself can be snorted
- Absorbed via the GI tract with an onset of effect between 20 minutes and 1 hour after consumption
- MDMA is profoundly serotonergic and can precipitate serotonin syndrome
Side effects associated with MDMA
| Minor side effects | Life-threatening side effects |
|---|---|
| Trismus | Hyperpyrexia > 41.5°C |
| Tachycardia | Rhabdomyolysis |
| Bruxism | Serotonin syndrome |
| Anxiety | Acute liver failure |
| Prolonged hangover | Hyponatremia and cerebral edema |
Signs and symptoms
| System | Minor or moderate overdose | Severe overdose |
|---|---|---|
| Cardiovascular | Disseminated Intravascular Coagulation (DIC) Intracranial hemorrhage Severe Hypotension or Hypertension Hypotensive bleeding |
|
| Central nervous system | Hyperreflexia Agitation Mental confusion Paranoia Stimulant psychosis | Cognitive and memory impairment potentially to the point of retrograde or anterograde amnesia Coma Convulsions Hallucinations Loss of consciousness Serotonin syndrome |
| Musculoskeletal | Muscle rigidity Rhabdomyolysis |
|
| Respiratory | Acute Respiratory Distress Syndrome | |
| Urinary | Acute kidney injury (AKI) | |
| Other | Cerebral edema Hepatitis Hyperpyrexia Hyponatremia |
Complications
- Neurological
- Cardiovascular
- Cardiac dysrhythmias
- Myocardial infarction
- Aortic dissection
- Intracranial hemorrhages
- GI
- Hepatotoxicity
- Liver failure
- Renal
- Rhabdomyolysis
- Acute renal failure
- Endocrine
- SIADH resulting in life-threatening hyponatremia
- Minor complications
- Increased muscle activity (such as bruxism, restless legs, and jaw clenching)
- Hyperactivity
- Insomnia
- Difficulty concentrating
- Feelings of restlessness
Risk factors
- Ingestion of several doses at once or in a short period
- Mixing MDMA with alcohol or other drugs
- Vigorous physical activity
- Use of MDMA in a hot environment
Diagnosis
- Blood glucose levels
- Electrolyte abnormalities
- Urine, potassium, BUN, creatinine, creatine phosphokinase levels, and myoglobin levels for the evaluation of rhabdomyolysis and renal injury
- LFTs for hepatotoxicity
- Aspirin, alcohol, acetaminophen levels, and urine drug screening
- ECG
- Head CT, lumbar punction
Management

Suggested reading
- Davies N, English W, Grundlingh J. MDMA toxicity: management of acute and life-threatening presentations. Br J Nurs. 2018;27(11):616-622.
- Nicholson Roberts, T., Thompson, J.P., 2013. Illegal substances in anaesthetic and intensive care practices. Continuing Education in Anaesthesia Critical Care & Pain 13, 42–46.
- Hall, A.P., Henry, J.A., 2006. Acute toxic effects of ‘Ecstasy’ (MDMA) and related compounds: overview of pathophysiology and clinical management. British Journal of Anaesthesia 96, 678–685.
Nerve Blocks App
Pain Medicine Assistant App
POCUS App
MSK Knee App
VetRA App
Nerve Block Manual
Regional Anesthesia Updates
Anesthesiology Manual
Anesthesiology Review
Anesthesia Updates 2025
Anesthesia Updates 2026
Pediatric Anesthesia Updates
Airway Management Updates
US Interventional Pain Manual
Pain Medicine Updates
Mastering Difficult IV Access
PACU Nursing Manual
RA Veterinary Manual